Document Detail


Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells.
MedLine Citation:
PMID:  16023584     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of the potent neurotoxin MPTP in producing a model for Parkinson's disease (PD) has allowed us to dissect the cellular processes responsible for both selective neuronal vulnerability and neuroprotection in idiopathic PD. It has been suggested that vesicular monoamine transporters (VMATs) play a critical neuroprotective role in MPP+ toxicity. However, little is known about how this detoxificative sequestration in dopaminergic (DAergic) neurons is regulated at the molecular and cellular levels. Using the DAergic cell line MN9D as an in vitro model, we found that overexpression of VMAT2 (a neuronal isoform of VMATs) protects the transformants from MPP+-induced toxicity, consistent with the previous work on fibroblastic CHO cells. We further found that the MN9D cells displayed lower expression levels of secretory vesicle proteins such as synaptophysin. Overexpression of synaptophysin in MN9D cells can significantly increase the resistance of the transformants to MPP+ toxicity. The co-expression of VMAT2 and synaptophysin has shown synergistic protection for the transformants, suggesting a role of synaptophysin in the biogenesis of secretory vesicles and in influencing the targeting of VMAT2 to these vesicles. Our work indicates that both the expression level of VMAT2 and capacity of vesicular packaging of DA are important in protecting DAergic cells from MPP+ toxicity.
Authors:
Carol X-Q Chen; Steven Y Huang; Limei Zhang; Yong-Jian Liu
Related Documents :
15168074 - Chemical nursing: phytosulfokine improves genetic transformation efficiency by promotin...
8269974 - Malignant cells have increased levels of common glycoprotein ligands of the endogenous ...
20702344 - An interlaboratory evaluation of the syrian hamster embryo cell transformation assay us...
22752974 - The characterization and quantitation of glycomic changes in cho cells during a bioreac...
12970064 - A truncated hmga1 gene induces proliferation of the 3t3-l1 pre-adipocytic cells: a mode...
9084724 - Consequences of attachment of helicobacter pylori to gastric cells.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neurobiology of disease     Volume:  19     ISSN:  0969-9961     ISO Abbreviation:  Neurobiol. Dis.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-07-18     Completed Date:  2005-08-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9500169     Medline TA:  Neurobiol Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  419-26     Citation Subset:  IM    
Affiliation:
Department of Neurology, University of Pittsburgh School of Medicine, W958 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Methyl-4-phenylpyridinium / toxicity*
Animals
Blotting, Western
CHO Cells
Cricetinae
Cricetulus
Dopamine / metabolism
Humans
Membrane Glycoproteins / metabolism*
Membrane Transport Proteins / metabolism*
Neurons / drug effects*,  metabolism
Neurotoxins / toxicity*
PC12 Cells
Rats
Secretory Vesicles / drug effects,  metabolism
Synaptophysin / metabolism*
Transfection
Vesicular Biogenic Amine Transport Proteins
Vesicular Monoamine Transport Proteins
Chemical
Reg. No./Substance:
0/Membrane Glycoproteins; 0/Membrane Transport Proteins; 0/Neurotoxins; 0/SLC18A2 protein, human; 0/Slc18a2 protein, rat; 0/Synaptophysin; 0/Vesicular Biogenic Amine Transport Proteins; 0/Vesicular Monoamine Transport Proteins; 48134-75-4/1-Methyl-4-phenylpyridinium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting.
Next Document:  The ubiquitin-proteasome system in Creutzfeldt-Jakob and Alzheimer disease: intracellular redistribu...